Design, synthesis, biological evaluation, and docking study of 4‐isochromanone hybrids bearing <i>N</i>‐benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part <scp>II</scp>)

Jia Wang, Chaolei Wang, Zheng Wu, Xinnan Li, Shengtao Xu, Jie Liu, Lan Qinying, Zheying Zhu, Jinyi Xu

Chemical Biology & Drug Design · 2017 · 19 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

A series of novel 4‐isochromanone compounds bearing N ‐benzyl pyridinium moiety were designed and synthesized as acetylcholinesterase ( AC hE) inhibitors. The biological evaluation showed that most of the target compounds exhibited potent inhibitory activities against AC hE. Among them, compound 1q possessed the strongest anti‐ AC hE activity with an IC 50 value of 0.15 n m and high AC hE/BuChE selectivity ( SI &gt; 5,000). Moreover, compound 1q had low toxicity in normal nerve cells and was relatively stable in rat plasma. Together, the current finding may provide a new approach for the discovery of novel anti‐Alzheimer's disease agents.

References

15